Baker Brothers Advisors - AVANIR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AVANIR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$652,807,000
+80.6%
38,513,713
+27.0%
6.66%
+46.3%
Q3 2014$361,543,000
+245.4%
30,330,877
+63.4%
4.55%
+255.2%
Q2 2014$104,670,000
+392.6%
18,558,487
+220.5%
1.28%
+374.8%
Q1 2014$21,250,000
+16.5%
5,790,139
+6.7%
0.27%
+5.1%
Q4 2013$18,240,000
-2.6%
5,428,591
+22.6%
0.26%
-3.4%
Q3 2013$18,733,000
+13.8%
4,428,591
+23.8%
0.27%
-18.4%
Q2 2013$16,462,0003,578,5910.33%
Other shareholders
AVANIR PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 2,295,000$38,900,0006.85%
Baker Brothers Advisors 38,513,713$652,807,0006.66%
Realm Partners LLC 300,000$5,085,0003.92%
Miura Global Management 2,758,000$46,748,0003.52%
WATER ISLAND CAPITAL LLC 10,612,846$179,887,740,0003.00%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 641,056$10,866,0002.72%
Verition Fund Management LLC 703,900$11,931,0002.67%
GLAZER CAPITAL, LLC 1,004,815$17,032,0002.46%
GARDNER LEWIS ASSET MANAGEMENT L P 716,994$12,153,0002.45%
Rock Springs Capital Management LP 1,100,000$18,645,0002.18%
View complete list of AVANIR PHARMACEUTICALS INC shareholders